Menu
Recruiting NCT06059313

Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders

Observational Behavioral Variant of Frontotemporal Disorder (bvFTD) Phenocopy Frontotemporal Dementia (phFTD) Frontal Variant of Alzheimer Disease Bipolar Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Submission of the NEO-PI-3 questionnaire, Submission of the Interpersonal Reactivity Index questionnaire (IRI).
Who it may be relevant to
Registry conditions: Behavioral Variant of Frontotemporal Disorder (bvFTD), Phenocopy Frontotemporal Dementia (phFTD), Frontal Variant of Alzheimer Disease, Bipolar Disorder. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Relationship Between Premorbid Personality Traits and Cognitive and Behavioral Disorders

Overview

Damages in frontal area present in neurodegenerative disease (frontotemporal degeneration, frontal variant of Alzheimer disease) and in psychiatric disease (bipolar disorder) can affect behavior and cognition including social cognition. Symptoms vary both quantitatively and qualitatively from disease to another and from person to person. It cannot be completely excluded that in some cases, factors of susceptibility such as premorbid personality traits lead to frontal fragility. The study will assess the relationship between premorbid profile using NEO-PI 3 inventory and cognitive and behavioral/psychobehavioral manifestations in patients with behavioral variant of frontotemporal disorder (bvFTD), phenocopy frontotemporal dementia (phFTD), frontal variant of Alzheimer disease, bipolar disorder characterized with frontal damages.

Interventions

  • Other Submission of the NEO-PI-3 questionnaire
    The questionnaire contains 240 statements. For each statement, the patient chooses the answer that best corresponds to their choice (FD: strongly disagree - D: disagree - N: neutral - A: agree - FA: strongly agree).
  • Other Submission of the Interpersonal Reactivity Index questionnaire (IRI)
    The test assesses two cognitive and two affective components of empathy that influence each other and affect attitudes and behaviors toward others.

Primary outcome measures

  • Premorbid personality traits [Time frame: Baseline]
Secondary outcome measures (1)
  • Interpersonal Reactivity Index (IRI) [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Patients with behavioral variant of frontotemporal disorder (bvFTD) according to Rascovsky criteria (2011) or patients with phénocopy frontotemporal dementia (phFTD) who fulfill criteria for possible bvFTD and have no imaging abnormalities or patients with frontal variant of Alzheimer disease according to Ossenkopele criteria (2022), or patient with bipolar disorder according to CIM 10 criteria
  • Score for Mini-mental state examination ≥ 18
  • Patient with caregiver who has who has known him/her in the 10 years preceding the disease onset.
  • Patient and caregiver consents (no opposition)

Exclusion criteria

  • Patient with no caregiver
  • Pregnant or breast feeding women

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

France · 1 center
  • CHU de Nantes — Nantes

Identifiers

NCT: NCT06059313 · RC23_0343

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗